Research & Projects

ESCMID Panorama

ESCMID Conference on Reviving Old Antibiotics

22 - 24 October 2014, Vienna, Austria

Poster Presentations

Posters will be presented on 22 - 23 October 2014.

P01Efficacy of Old Antibiotics against Commonly Isolated Microorganisms in a Tertiary Care Hospital

Majumder, S. (India)

P02

Comparative in vitro activity of temocillin and other beta-lactams against Pseudomonas aeruginosa isolated from cystic fibrosis patients

Chalhoub, H. (Belgium)

P03

In vitro activity of Fosfomycin and Tigecycline against Carbapenemase Producing Enterobacteriacae in a tertiary care hospital in Singapore

Choudhury, S. (Singapore)
P04In vitro Activity of NitroxolineNaber, K.G. (Germany)
P05

Prevalence of multidrug resistant Klebsiella pneumoniae strains producing carbapenemases (MDR-KPC) and increase of resistance to colistin

Bartolini, A. & Santacatterin, E. (Italy)
P06

Old Drugs for New Bugs, the Chaotic Lebanese Scenario: A Developing Country's Perspective

Bizri, A. (Lebanon)
P07

Resistant strains of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit

Yergaliyeva, A. (Kazakhstan)
P08Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric gram-negative Bacteria and Activity of Nitrofurantoin in the Era of ESBLFatemi, A. (Iran)
P09

INFLUENCE OF ANTIBIOTIC GENTAMICIN ON MITOGEN-INDUCED TRYPTOPHAN BREAKDOWN IN VITRO

Gostner, J.M. (Austria)
P10

IN VITRO ACTIVITY OF RIFAXIMIN COMBINED WITH COLISTIN OR POLYMYXIN B VERSUS MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIA. A POTENTIAL COMBINATION REGIMEN FOR SELECTIVE DECOMNTAMINATION OF THE DIGESTIVE TRACT?

Betts, J.W. (United Kingdom)
P11

THE INVESTIGATION OF COLISTIN RESISTANCE MECHANISMS IN CLINICAL ISOLATES OF KLEBSIELLA PNEUMONIAE

Kocsis, B. (Hungary)
P12A deletion in lumazine synthase contributes to nitrofurantoin resistance in Escherichia coliXavier, B.B. (Belgium)
P13

Resistance CAMRSA isolates from healthy population to non beta-lactam antibiotics in Pomoravlje district

Petrović Jeremić, L.J. (Serbia)
P15High macrolide resistant Moraxella catarrhalis and development of an allele-specific PCR assay for detection of 23S rRNA gene A2330T mutation: A 3 year study at a Chinese tertiary hospital Liu, Y.L. (China)
P17Heteroresistance to colistin in Klebsiella pneumoniaeXavier, B.B. (Belgium)
P18A NOVEL TRIPLE COMBINATION OF FOSFOMYCIN, CHLORAMPHENICOL AnD COLISTIN FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTIONBetts, J.W. (United Kingdom)
P19INTERACTIONS BETWEEN DOXYCYCLINE AND NON-ANTIBIOTIC DRUGS USED IN CANINE MEDICINEMaaland, M.G. (Denmark)
P20Bactericidal activity of Ciprofloxacin Dry Powder for Inhalation (DPI) in a hollow fiber (HF) modelGlenschek-Sieberth, M. (Germany)
P21GALLERIA MELLONELLA: AN IN VIVO MODEL FOR ASSESSING THE EFFICACY OF COLISTIN COMBINATIONS WITH BROAD SPECTRUM ANTIBIOTICS AGAINST BIOFILM FORMING ACINETOBACTER BAUMANNII INFECTIONSGillett, A.R. (United Kingdom)
P22NOVEL ANTIVIRULENCE AGENTS SENSITIZE MRSA TO BETA-LACTAM ANTIBIOTICSShoham, M. (United States)
P23Phosphonopeptides Revisited, in the Era of Multidrug-Resistant EnterobacteriaceaeMarrs, E.C.L. (United Kingdom)
P24Method for detecting levels of antibiotics in blood paves the way to individualized treatmentsWafula Ndieyira, J. (United Kingdom)
P25PHARMACOKINETICS OF COLISTIN AFTER THE ADMINISTRATION OF TWO DIFFERENT LOADING DOSES OF COLISTIN METHANESULFONATE (CMS) IN CRITICALLY ILL PATIENTSPachón- Ibañez, M.E. (Spain)
P26Clinical Pharmacokinetics of Temocillin in Patients With End Stage Renal Disease Undergoing HaemodialysisMiranda Bastos, A.C. (Belgium)
P27DIFFERENCE IN CLEARANCE OF VANCOMYCIN BY RACSungmin Kiem (Rep. of Korea)
P28Revisiting paediatric penicillin pharmacokinetics: the feasIbility of opportunistic sampling strategiesBarker, C.I. (United Kingdom)
P29RISK ASSESSMENT FOR AMIKACIN INHALE IN ICU PATIENTS USING WHOLE-BODY PHYSIOLOGICALLY-BASED PK-MODELSStass, H. (Germany)
P30

LUNG DEPOSITION OF CIPROFLOXACIN DPI IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) OR NON-CYSTIC FIBROSIS BRONCHIECTASIS (NCFB)

Stass, H. (Germany)
P31Efficacy of ciprofloxacin against resistant P. aeruginosa isolated from non-cystic fibrosis bronchiectasis (NCFB) patients considering lung pharmacokinetics (PK) after Ciprofloxacin DPI treatmentGlenschek-Sieberth, M. (Germany)
P32Inhalatory antibiotic therapy in cystic fibrosis and emergence of colistin resistant gram-negative non-fermenting bacteria: a new problem in pulmonary infection treatment?Morelli, P. (Italy)
P33STUDY OF THE USE OF COLISTIN IN A LARGE ORTHOPEDIC/TRAUMA HOSPITAL OF GREECEStefani, D. (Greece)
P34Multiple-dose regimen of intravenous and oral fosfomycin tromethamine as a potential therapy for the treatment of systemic infections due to multidrug-resistant bacteriaOrtiz Zacarías N.V. (Netherlands)
P35

NITROXOLINE FOR TREATMENT OF UNCOMPLICATED UTI IPD-METAANALYSIS OF FOUR CONTROLLED CLINICAL STUDIES

Naber, K.G. (Germany)